Investigation of SARS-CoV-2 in tear and conjunctival secretions of hospitalized patients with clinically-confirmed COVID-19 pneumonia

BMC Infect Dis. 2021 Sep 6;21(1):918. doi: 10.1186/s12879-021-06630-6.

Abstract

Background: The aim of this study was to demonstrate the presence of the virus in tear and conjunctival secretions of clinically-confirmed COVID-19 pneumonia patients.

Methods: This prospective study was conducted at Bakirkoy Dr. Sadi Konuk Training and Research Hospital (2020/190). Nasopharyngeal and ocular samples were obtained by swab technique and investigated by RT-PCR.

Results: A total of 83 patients were included. The mean age was 61.88 ± 16.04 years. 28.92% of the patients had mild, 65.06% moderate and 6.02% severe pneumonia radiologically. RT-PCR was positive in 31 (37.35%) patients in the first nasopharyngeal swabs and in 19 (22.89%) in the second swabs. 17 of 19 patients had positive both first and second nasopharyngeal swabs; only the second swabs of two patients were positive. The first conjunctival swabs RT-PCR were positive in 5 out of 83 clinically-confirmed patients or 33 laboratory-confirmed patients (rates: 6.02% and 15.15%). There were no positives detected in the second conjunctival swabs.

Conclusions: SARS-CoV-2 can be detected in the conjunctival swabs of patients with COVID-19 pneumonia.

Keywords: COVID-19; Conjunctival swab; Nasopharyngeal swab; Pneumonia; SARS-CoV-2.

MeSH terms

  • COVID-19*
  • Conjunctiva
  • Humans
  • Middle Aged
  • Prospective Studies
  • RNA, Viral
  • SARS-CoV-2*

Substances

  • RNA, Viral